Overview

An Efficacy Study of BCS Clearing the Oral Colonized Bacterium in Hospitalized Patients With COPD

Status:
Unknown status
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
The purpose of study is to evaluate the efficacy and safety of Benzalkonium Chloride Solution clearing the oral colonized bacterium in hospitalized patients with COPD.
Phase:
Phase 4
Details
Lead Sponsor:
Lustre Pharmaceutical Lab Co., Ltd
Treatments:
Benzalkonium Compounds
Pharmaceutical Solutions